3'-Amino-2',3'-dideoxyribonucleosides of some pyrimidines: synthesis and biological activities. 1983

T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway

3'-Amino-2',3'-dideoxyribonucleosides of thymine, uracil, and 5-iodouracil (1-3) were synthesized from the corresponding 2'-deoxyribonucleosides via the threo-3'-chloro and the erythro-3'-azido derivatives. Corresponding aminonucleosides of 5-bromouracil, 5-chlorouracil, and 5-fluorouracil (4-6) were synthesized enzymatically with 3'-amino-2',3'-dideoxythymidine as the aminopentosyl donor and thymidine phosphorylase (EC 2.4.2.4) as the catalyst. 3'-Amino-2',3'-dideoxycytidine (7) was synthesized by amination of the 3'-azido precursor of 3'-amino-2',3'-dideoxyuridine. The biological activity of 3'-amino-2',3'-dideoxy-5-fluorouridine (6) was notable among this group of aminonucleosides. It had an ED50 of 10 microM against adenovirus and was not appreciably cytotoxic to mammalian cells in culture. It also had activity against some Gram-positive bacteria but not against a variety of Gram-negative bacteria. The other aminonucleosides (1-5 and 7) lacked or exhibited weak antiviral and antibacterial activities. The only compounds in this group that were appreciably toxic to mammalian cells in culture were the thymidine and deoxycytidine analogues (1 and 7).

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003239 Connective Tissue Cells A group of cells that includes FIBROBLASTS, cartilage cells, ADIPOCYTES, smooth muscle cells, and bone cells. Cell, Connective Tissue,Cells, Connective Tissue,Connective Tissue Cell
D003853 Deoxyribonucleosides A purine or pyrimidine base bonded to DEOXYRIBOSE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
May 1971, Journal of medicinal chemistry,
T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
April 1976, Journal of medicinal chemistry,
T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
July 1989, Die Pharmazie,
T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
January 1971, Progress in medicinal chemistry,
T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
January 1991, Die Pharmazie,
T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
January 1970, Journal of the Chemical Society. Perkin transactions 1,
T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
January 1971, Journal of pharmaceutical sciences,
T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
January 1999, Nucleic acids symposium series,
T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
January 1968, Journal of medicinal chemistry,
T A Krenitsky, and G A Freeman, and S R Shaver, and L M Beacham, and S Hurlbert, and N K Cohn, and L P Elwell, and J W Selway
January 2009, Arzneimittel-Forschung,
Copied contents to your clipboard!